29 Jun

University and Big Pharma JV’s $145 million take-off is a big boost for tech transfer dealmaking

Significant funding is a success for joint venture biotech Apollo, which offers an innovative approach to creating and monetising university IP in the life sciences.

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth